The critical enzyme beta-secretase1 (BACE1) is known to be elevated in brains with sporadic Alzheimer disease (AD). Scientists have now found increased levels of BACE1 in brains with mild cognitive impairment, suggesting that BACE1 activity is important for conversion of mild cognitive impairment to AD and may be an early indicator of AD.